Drugs / Clotinab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00841438 | Jul 2007 → Dec 2009 | myocardial infarction | Yonsei University | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clotinab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00841438 ↗ |
| Action | Inhibit | “BACKGROUND: This study investigated the efficacy and the safety of the upstream glycoprotein (Gp) IIb/IIIa inhibitor (clotinab; ISU ABXIS, Seoul, Republic of Korea) under...” PMID 22146757 ↗ Dec 2011 |
| Route | Intravenous | “Clotinab: IV bolus 0.25 mg per Kg and a 12-hour IV infusion 0.125 μg per kg” NCT00841438 ↗ |